Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib

por Ali, Siraj M., He, Je, Carson, Wade, Stephens, Phil J., Fiorillo, Joseph, Lipson, Doron, Palmer, Gary A., Ross, Jeffrey S., Miller, Vincent A., Sharman, Jeffrey
Publicado 2014

A review of the incidence of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax and debulking strategies

por Sharman, Jeffrey P., Biondo, Juliana M. L., Boyer, Michelle, Fischer, Kirsten, Hallek, Michael, Jiang, Dingfeng, Kater, Arnon P., Porro Lurà, Michele, Wierda, William G.
Publicado 2022

A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors

por Sharman, Jeffrey P., Wheler, Jennifer J., Einhorn, Lawrence, Dowlati, Afshin, Shapiro, Geoffrey I., Hilton, John, Burke, John M., Siddiqi, Tanya, Whiting, Nancy, Jalal, Shadia I.
Publicado 2019